S100 proteins and their influence on pro-survival pathways in cancer

Biochemistry and Cell Biology

Volumn 82, Issue 4, 2004, Pages 508-515

  Emberley, Ethan D ^a,b   Murphy, Leigh C ^a,b   Watson, Peter H ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b 336 Basic Medical Sciences Building ^*  (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CELLS; GENES; MOLECULES; POSITIVE IONS; SIGNALING; TISSUE; TUMORS;

CYTOSKELETON DYNAMICS; ENZYME ACTIVITY; HOMEOSTASIS; PROTEIN-PROTEIN INTERACTIONS;

PROTEINS;

PROTEIN S 100;

AMINO ACID SEQUENCE; APOPTOSIS; CALCIUM HOMEOSTASIS; CANCER; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; CONFERENCE PAPER; CYTOSKELETON; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; ANIMALS; APOPTOSIS; CALCIUM; CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; CELL MEMBRANE; CELL SURVIVAL; CHEMOTACTIC FACTORS; CYTOSKELETON; DISEASE PROGRESSION; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NERVE GROWTH FACTORS; S100 PROTEINS;

EID: 4644330118     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o04-052     Document Type: Conference Paper

References (75)

1. Al Haddad, S., Zhang, Z., Leygue, E., Snell, L., Huang, A., Niu, Y., et al. 1999. Psoriasin (S100A7) expression and invasive breast cancer. Am. J. Pathol. 155: 2057-2066.
2. Alowami, S., Qing, G., Emberley, E., Snell, L., and Watson, P.H. 2003. Psoriasin (S100A7) expression is altered during skin tumorigenesis. BMC Dermatol. 3: 1.
3. Bae, M.K., Ahn, M.Y., Jeong, J.W., Bae, M.H., Lee, Y.M., Bae, S.K., et al. 2002. Jab1 interacts directly with HIF-1alpha and regulates its stability. J. Biol. Chem. 277: 9-12.
4. Barraclough, R., Kimbell, R., and Rudland, P.S. 1984. Increased abundance of a normal cell mRNA sequence accompanies the conversion of rat mammary cuboidal epithelial cells to elongated myoepithelial-like cells in culture. Nucleic Acids Res. 12: 8097-8114.
5. Baudier, J., Delphin, C., Grunwald, D., Khochbin, S., and Lawrence, J.J. 1992. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Proc. Natl. Acad. Sci. U.S.A. 89: 11 627-11 631.
6. Bech-Otschir, D., Kraft, R., Huang, X., Henklein, P., Kapelari, B., Pollmann, C., and Dubiel, W. 2001. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J. 20: 1630-1639.
7. Bianchi, R., Pula, G., Ceccarelli, P., Giambanco, I., and Donato, R., 1992. S-100 protein binds to annexin II and p11, the heavy and light chains of calpactin I. Biochim. Biophys. Acta, 1160: 67-75.
8. Boni, R., Burg, G., Doguoglu, A., Ilg, E.C., Schafer, B.W., Muller, B., and Heizmann, C.W. 1997. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Br. J. Dermatol. 137: 39-43.
9. Breen, E.C., and Tang, K. 2003. Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J. Cell Biochem. 88: 848-854.
10. Brodersen, D.E., Etzerodt, M., Madsen, P., Celis, J.E., Thogersen, H.C., Nyborg, J., and Kjeldgaard, M. 1998. EF-hands at atomic resolution: the structure of human psoriasin (S100A7) solved by MAD phasing. Structure, 6: 477-489.
11. Brouard, M.C., Saurat, J.H., Ghanem, G., and Siegenthaler, G. 2002. Urinary excretion of epidermal-type fatty acid-binding protein and S100A7 protein in patients with cutaneous melanoma. Melanoma Res. 12: 627-631.
12. Camby, I., Nagy, N., Lopes, M.B., Schafer, B.W., Maurage, C.A., Ruchoux, M.M., et al. 1999. Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins. Brain Pathol. 9: 1-19.
13. Celis, J.E., Rasmussen, H.H., Vorum, H., Madsen, P., Honore, B., Wolf, H., and Orntoft, T.F. 1996. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J. Urol. 155: 2105-2112.
14. Chen, H., Fernig, D.G., Rudland, P.S., Sparks, A., Wilkinson, M.C., and Barraclough, R. 2001. Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka). Biochem. Biophys. Res. Commun. 286: 1212-1217.
15. Claret, F.X., Hibi, M., Dhut, S., Toda, T., and Karin, M. 1996. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature, 383: 453-457.
16. Davey, G.E., Murmann, P., and Heizmann, C.W. 2001. Intracellular Ca2+ and Zn2+ levels regulate the alternative cell density-dependent secretion of S100B in human glioblastoma cells. J. Biol. Chem. 276: 30 819-30 826.
17. Davies, B.R., Davies, M.P., Gibbs, F.E., Barraclough, R., and Rudland, P.S. 1993. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene, 8: 999-1008.
18. Davies, M.P., Rudland, P.S., Robertson, L., Parry, E.W., Jolicoeur, P., and Barraclough, R. 1996. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene, 13: 1631-1637.
19. Davies, B.R., O'Donnell, M., Durkan, G.C., Rudland, P.S., Barraclough, R., Neal, D.E., and Mellon, J.K. 2002. Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer. J. Pathol. 196: 292-299.
20. Dechend, R., Hirano, F., Lehmann, K., Heissmeyer, V., Ansieau, S., Wulczyn, F.G., et al. 1999. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators. Oncogene, 18: 3316-3323.
21. Di Nuzzo, S., Sylva-Steenland, R.M., Koomen, C.W., de Rie, M.A., Das, P.K., Bos, J.D., and Teunissen, M.B. 2000. Exposure to UVB induces accumulation of LFA-1+ T cells and enhanced expression of the chemokine psoriasin in normal human skin. Photochem. Photobiol. 72: 374-382.
22. Donato, R. 1999. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim. Biophys. Acta, 1450: 191-231.
23. Donato, R. 2001. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33: 637-668.
24. Donato, R. 2003. Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 60: 540-551.
25. El Rifai, W., Moskaluk, C.A., Abdrabbo, M.K., Harper, J., Yoshida, C., Riggins, G.J., et al. 2002. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res. 62: 6823-6826.
26. Emberley, E.D., Gietz, R.D., Campbell, J.D., HayGlass, K.T., Murphy, L.C., and Watson, P.H. 2002. RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer. BMC Cancer, 2: 28.
27. Emberley, E.D., Niu, Y., Leygue, E., Tomes, L., Gietz, R.D., Murphy, L.C., and Watson, P.H. 2003a. Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res. 63: 1954-1961.
28. Emberley, E.D., Niu, Y., Njue, C., Kliewer, E.V., Murphy, L.C., and Watson, P.H. 2003b. Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer. Clin. Cancer Res. 9: 2627-2631.
29. Emberley, E.D., Curtis, L., Myers, J.N., Murphy, L.C., and Watson, P.H. 2004. Psoriasin (S100A7) stimulates pro-survival pathways through activation of Jab1 in breast cancer. Proceedings of the 95th Annual Meeting of the American Association for Cancer Research, Orlando, Fla., 27-31 March 2004 [abstract 4126]. Vol. 45.
30. Enerback, C., Porter, D.A., Seth, P., Sgroi, D., Gaudet, J., Weremowicz, S., et al. 2002. Psoriasin expression in mammary epithelial cells in vitro and in vivo. Cancer Res. 62: 43-47.
31. Feng, G., Xu, X., Youssef, E.M., and Lotan, R. 2001. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis. Cancer Res. 61: 7999-8004.
32. Filipek, A., Wojda, U., and Lesniak, W. 1995. Interaction of calcyclin and its cyanogen bromide fragments with annexin II and glyceraldehyde 3-phosphate dehydrogenase. Int. J. Biochem. Cell Biol. 27: 1123-1131.
33. Golitsina, N.L., Kordowska, J., Wang, C.L., and Lehrer, S.S. 1996. Ca2+-dependent binding of calcyclin to muscle tropomyosin. Biochem. Biophys. Res. Commun. 220: 360-365.
34. Grigorian, M., Ambartsumian, N., Lykkesfeldt, A.E., Bastholm, L., Elling, F., Georgiev, G., and Lukanidin, E. 1996. Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int. J. Cancer, 67: 831-841.
35. Grigorian, M., Andresen, S., Tulchinsky, E., Kriajevska, M., Carlberg, C., Kruse, C., et al. 2001. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J. Biol. Chem. 276: 22 699-22 708.
36. Gupta, S., Hussain, T., MacLennan, G.T., Fu, P., Patel, J., and Mukhtar, H. 2003. Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma. J. Clin. Oncol. 21: 106-112.
37. Hagens, G., Masouye, I., Augsburger, E., Hotz, R., Saurat, J.H., and Siegenthaler, G. 1999. Calcium-binding protein S100A7 and epidermal-type fatty acid-binding protein are associated in the cytosol of human keratinocytes. Biochem. J. 339(2): 419-427.
38. Hamberg, A.P., Korse, C.M., Bonfrer, J.M., and de Gast, G.C. 2003. Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma. Melanoma Res. 13: 45-49.
39. Heizmann, C.W., Fritz, G., and Schafer, B.W. 2002. S 100 proteins: structure, functions and pathology. Front Biosci. 7: d1356-d1368.
40. Hernan, R., Fasheh, R., Calabrese, C., Frank, A.J., Maclean, K.H., Allard, D., et al. 2003. ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma. Cancer Res. 63: 140-148.
41. Hsieh, H.L., Schafer, B.W., Sasaki, N., and Heizmann, C.W. 2003. Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem. Biophys. Res. Commun. 307: 375-381.
42. Huttunen, H.J., Kuja-Panula, J., Sorci, G., Agneletti, A.L., Donato, R., and Rauvala, H. 2000. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 275: 40 096-40 105.
43. Ilg, E.C., Schafer, B.W., and Heizmann, C.W. 1996. Expression pattern of S100 calcium-binding proteins in human tumors. Int. J. Cancer, 68: 325-332.
44. Jinquan, T., Vorum, H., Larsen, C.G., Madsen, P., Rasmussen, H.H., Gesser, B., et al. 1996. Psoriasin: a novel chemotactic protein. J. Invest. Dermatol. 107: 5-10.
45. Kim, J., Kim, J., Yoon, S., Joo, J., Lee, Y., Lee, K., et al. 2002. S100A6 protein as a marker for differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma. Hepatol. Res. 23: 274-286.
46. Komatsu, K., Andoh, A., Ishiguro, S., Suzuki, N., Hunai, H., Kobune-Fujiwara, Y., et al. 2000. Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas. Clin. Cancer Res. 6: 172-177.
47. Kriajevska, M., Tarabykina, S., Bronstein, I., Maitland, N., Lomonosov, M., Hansen, K., Georgiev, G., and Lukanidin, E. 1998. Metastasis-associated Mts1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin. J. Biol. Chem. 273: 9852-9856.
48. Kulski, J.K., Lim, C.P., Dunn, D.S., and Bellgard, M. 2003. Genomic and phylogenetic analysis of the S100A7 (Psoriasin) gene duplications within the region of the S100 gene cluster on human chromosome 1q21. J. Mol. Evol. 56: 397-406.
49. Lakshmi, M.S., Parker, C., and Sherbet, G.V. 1993. Metastasis associated MTS1 and NM23 genes affect tubulin polymerisation in B16 melanomas: a possible mechanism of their regulation of metastatic behaviour of tumours. Anticancer Res. 13: 299-303.
50. Leygue, E., Snell, L., Hiller, T., Dotzlaw, H., Hole, K., Murphy, L.C., and Watson, P.H. 1996. Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res. 56: 4606-4609.
51. Lin, J., Blake, M., Tang, C., Zimmer, D., Rustandi, R.R., Weber, D.J., and Carrier, F. 2001. Inhibition of p53 transcriptional activity by the S100B calcium-binding protein. J. Biol. Chem. 276: 35 037-35 041.
52. Madsen, P., Rasmussen, H.H., Leffers, H., Honore, B., Dejgaard, K., Olsen, E., et al. 1991. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J. Invest. Dermatol. 97: 701-712.
53. Maelandsmo, G.M., Florenes, V.A., Mellingsaeter, T., Hovig, E., Kerbel, R.S., and Fodstad, O. 1997. Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int. J. Cancer, 74: 464-469.
54. Mandal, M., Jasser, S., Yigitbasi, O., Patel, V., Gutkind, S., Wang, J., Coombes, K., Emberley, E., Watson, P.H., El-Naggar, A., Younes, M., Hittleman, W.N., and Myers, J.N. 2004. S100A7 (Psoriasin) mediates anoikis resistance and tumor progression in squamous cell carcinoma of the oral cavity. Proceedings of the 95th Annual Meeting of the American Association for Cancer Research, Orlando, Fla., 27-31 March 2004 [abstract 4901]. Vol. 45.
55. Mandinova, A., Atar, D., Schafer, B.W., Spiess, M., Aebi, U., and Heizmann, C.W. 1998. Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. J. Cell Sci. 111(14): 2043-2054.
56. Mani, R.S., McCubbin, W.D., and Kay, C.M. 1992. Calcium-dependent regulation of caldesmon by an 11-kDa smooth muscle calcium-binding protein, caltropin. Biochemistry, 31: 11 896-11 901.
57. Millward, T.A., Heizmann, C.W., Schafer, B.W., and Hemmings, B.A. 1998. Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins. EMBO J. 17: 5913-5922.
58. Moog-Lutz, C., Bouillet, P., Regnier, C.H., Tomasetto, C., Mattei, M.G., Chenard, M.P., et al. 1995. Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22. Int. J. Cancer, 63: 297-303.
59. Most, P., Boerries, M., Eicher, C., Schweda, C., Ehlermann, P., Pleger, S.T., et al. 2003. Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2). J. Biol. Chem. 278: 48 404-48 412.
60. Nagy, N., Brenner, C., Markadieu, N., Chaboteaux, C., Camby, I., Schafer, B.W., et al. 2001. S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration. Lab. Invest. 81: 599-612.
61. Niki, I., Okazaki, K., Iino, S., Kobayashi, S., and Hidaka, H. 1997. Calcyclin, a calcium-binding protein, which regulates insulin secretion from the permeabilized pancreatic beta-cell. Adv. Exp. Med. Biol. 426: 85-89.
62. Nikitenko, L.L., Lloyd, B.H., Rudland, P.S., Fear, S., and Barraclough, R. 2000. Localisation by in situ hybridisation of S100A4 (p9Ka) mRNA in primary human breast tumour specimens. Int. J. Cancer, 86: 219-228.
63. Ruse, M., Lambert, A., Robinson, N., Ryan, D., Shon, K.J., and Eckert, R.L. 2001. S100A7, S100A10, and S100A11 are transglutaminase substrates. Biochemistry, 40: 3167-3173.
64. Schafer, B.W., and Heizmann, C.W. 1996. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem. Sci. 21: 134-140.
65. Scotto, C., Deloulme, J.C., Rousseau, D., Chambaz, E., and Baudier, J. 1998. Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis. Mol. Cell. Biol. 18: 4272-4281.
66. Sorci, G., Riuzzi, F., Agneletti, A.L., Marchetti, C., and Donato, R. 2004. S100B causes apoptosis in a myoblast cell line in a RAGE-independent manner. J. Cell. Physiol. 199: 274-283.
67. Sudo, T., and Hidaka, H. 1998. Regulation of calcyclin (S100A6) binding by alternative splicing in the N-terminal regulatory domain of annexin XI isoforms. J. Biol. Chem. 273: 6351-6357.
68. Takenaga, K., Nakamura, Y., Sakiyama, S., Hasegawa, Y., Sato, K., and Endo, H. 1994. Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin. J. Cell. Biol. 124: 757-768.
69. Takenaga, K., Nakamura, Y., and Sakiyama, S. 1997a. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Oncogene, 14: 331-337.
70. Takenaga, K., Nakanishi, H., Wada, K., Suzuki, M., Matsuzaki, O., Matsuura, A., and Endo, H. 1997b. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin. Cancer Res. 3: 2309-2316.
71. Tavakkol, A., Zouboulis, C.C., Duell, E.A., and Voorhees, J.J. 1994. A retinoic acid-inducible skin-specific gene (RIS-1/psoriasin): molecular cloning and analysis of gene expression in human skin in vivo and cultured skin cells in vitro. Mol. Biol. Rep. 20: 75-83.
72. Tonini, G.P., Casalaro, A., Cara, A., and Di Martino, D. 1991. Inducible expression of calcyclin, a gene with strong homology to S-100 protein, during neuroblastoma cell differentiation and its prevalent expression in Schwann-like cell lines. Cancer Res. 51: 1733-1737.
73. Wicki, R., Franz, C., Scholl, F.A., Heizmann, C.W., and Schafer, B.W. 1997. Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium, 22: 243-254.
74. Yonemura, Y., Endou, Y., Kimura, K., Fushida, S., Bandou, E., Taniguchi, K., et al. 2000. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin. Cancer Res. 6: 4234-4242.
75. Zimmer, D.B., Cornwall, E.H., Landar, A., and Song, W. 1995. The S100 protein family: history, function, and expression. Brain Res. Bull. 37: 417-429.